Navigation Links
Proteolix Names Matthew Ferguson to Newly-Created Position of Chief Financial Officer
Date:2/25/2008

SOUTH SAN FRANCISCO, Calif., Feb. 25 /PRNewswire/ -- Proteolix, Inc., a clinical-stage company engaged in the development of novel pharmaceutical therapies for the treatment of cancer and immunological conditions, announced that it has appointed Matthew Ferguson to the new position of Chief Financial Officer. Mr. Ferguson brings extensive experience arranging financing and managing rapid growth in both life sciences and technology companies.

"We are delighted to have Matt on board as a key member of the Proteolix management team," said Susan Molineaux, Ph.D., the Company's President and CEO. "His experience building teams and infrastructure in high-growth environments and securing financing in both the private and public markets will serve Proteolix well as we continue to advance our clinical and research programs."

Before joining Proteolix, Mr. Ferguson served as CFO at medical device maker FoxHollow Technologies, Inc. During his five-year tenure there, the company advanced its flagship technology for the treatment of peripheral arterial disease through development, FDA approval and commercial launch in the U.S. Mr. Ferguson led FoxHollow's 2004 initial public offering and played a significant role in the company's 2007 merger with ev3 Inc. Mr. Ferguson previously held a variety of financial management and business development positions at ChannelPoint, Inc. and Hewlett-Packard. Mr. Ferguson holds an M.B.A. from the University of California at Berkeley and M.S. and B.S. degrees in engineering from the University of Pennsylvania and Stanford University, respectively.

"The Proteolix opportunity is driven by an expert team, a large unmet clinical need and compelling early clinical results for carfilzomib," commented Mr. Ferguson. "I look forward to contributing my skills and experience towards our dual goals of improving the lives of patients and generating substantial returns for our shareholders."

About Proteolix

Proteolix,
'/>"/>

SOURCE Proteolix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Proteolix Announces Clinical Results With Carfilzomib to be Reported at ASH 2007 Annual Meeting
2. Accident Fund Names General Agency Company its 2007 Agency of the Year
3. American Laser Centers Names Bill Van Huis as Chief Revenue Officer
4. Omron Healthcare Names New Chief Operating Officer Bob Kondraske
5. Birla Sun Life Insurance Names Quest Diagnostics its Exclusive Provider of Health Assessment Services in India
6. WeissComm Partners Names Tom Jones Managing Director to Deepen Global Product Communications Offering
7. Wyeth Consumer Healthcare Names New Head of Global R&D
8. Spectragenics Names Rpr Marketing Communications Agency of Record
9. Concentric Medical Names Kimberly Bridges as Vice President of Sales, Announces Receipt of $15 Million Growth Funding
10. Southern Research Institute Names Blaine Knight Vice President of Drug Discovery
11. CTG Names William D. McGuire a Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2014)... me out to the ballgame, doesn,t exactly conjure up ... likely culprits include French fries, soda and the occasional ... play youth baseball, eating unhealthy food during practices and ... researchers at Wake Forest Baptist Medical Center. The study, ... Obesity , found that high-calorie snacks and sugar-sweetened drinks ...
(Date:4/24/2014)... the relevance of palliation in advanced cancer are ... trials (RCTs). This is the result of an ... Efficiency in Health Care (IQWiG), which has now ... external experts, IQWiG analysed studies on four solid ... and pancreatic cancer. For this purpose, the research ...
(Date:4/24/2014)... one of 30 grants from the National Cancer Institute ... in its new National Clinical Trials Network ... investigators charged with distributing resources in a more effective ... reflects recommendations from a 2010 Institute of Medicine ... Faster design, launch, and completion of clinical ...
(Date:4/23/2014)... pilot study by Massachusetts General Hospital (MGH) investigators may ... treatment for a serious medical problem use of ... caused by the Clostridium difficile ( C. ... online in the journal Clinical Infectious Diseases , ... material from donors unrelated to patients was as successful ...
(Date:4/23/2014)... M.D., scientific director at the National Institute of Arthritis ... the 2014 recipient of the Ross Prize in Molecular ... Molecular Medicine . The award will be given ... Sciences in Manhattan, followed by scientific presentations by Dr. ... the National Institutes of Health. , The award, which ...
Breaking Medicine News(10 mins):Health News:Take the bat, leave the candy 2Health News:Palliation is rarely a topic in studies on advanced cancer 2Health News:Palliation is rarely a topic in studies on advanced cancer 3Health News:Dartmouth awarded lead role in NCI clinical trials network 2Health News:Dartmouth awarded lead role in NCI clinical trials network 3Health News:Use of frozen material for fecal transplant successfully treats C. difficile infection 2Health News:Use of frozen material for fecal transplant successfully treats C. difficile infection 3Health News:NIH scientist to receive Ross Prize in Molecular Medicine 2
... and dairy products, study finds, , FRIDAY, June 26 ... products can increase your risk for pancreatic cancer, researchers ... cancer, which is usually fatal, is the fourth-leading cause ... factors for developing the disease have been identified, including ...
... Calif., June 26 Discus Dental, LLC ("Discus") today announced ... court against Florida-based BSML, Inc. ("BSML") charging BSML with breach ... its lawsuit, Discus seeks to end a license agreement with ... order prohibiting BSML from future use of the trademark, and ...
... of Company Exemplifies the Best in Retirement Living , , ... housing will outpace supply in the coming years. Couple that trend with ... the senior housing industry looks very different than it did a decade ... Living, a national leader in senior living ...
... breach of contract , , DALLAS, June 26 A ... two years ago won again Thursday, when an appellate court affirmed ... Court of Appeals for the Fifth District of Texas at Dallas ... 2007 judgment against Pinnacle Anesthesia Consultants, P.A., which provides obstetric anesthesiology ...
... , NEW YORK, June 26 Selecciones , ... the American Heart Association,s (AHA) Go Red For ... retailers, for a second consecutive year in the multi-platform awareness program, ... to the threat of heart disease. , , To ...
... deadlier than a heart attack, experts say, with chances for ... star Michael Jackson probably did not die on Thursday of ... sudden cardiac arrest, experts say. , It,s not yet clear ... Angeles home, but that assumption has been made by many ...
Cached Medicine News:Health News:Eating Animal Fat May Lead to Pancreatic Cancer 2Health News:Eating Animal Fat May Lead to Pancreatic Cancer 3Health News:Discus Dental Files Suit to Protect BriteSmile(R) Trademark 2Health News:Aegis Living Was Created To Place People First in Senior and Assisted Living Communities 2Health News:Aegis Living Was Created To Place People First in Senior and Assisted Living Communities 3Health News:Appeals Court OKs Multimillion-Dollar Judgment for Dallas Doctor 2Health News:Photos: Selecciones, Reader's Digest, The American Heart Association's Go Red For Women and Macy's Reach Hispanic Women With Message of Heart Health 2Health News:Jackson's Death Puts Spotlight on Sudden Cardiac Arrest 2Health News:Jackson's Death Puts Spotlight on Sudden Cardiac Arrest 3
(Date:1/15/2014)... FRANKLIN, Ohio , Jan. 15, 2014  A novel wearable ... it easy and painless for patients to self-inject prescription drugs ... of disorders, including cancer, blood diseases, autoimmune deficiencies, and genetic ... expected to grow to $220B by 2018, according to analysts.   ...
(Date:1/14/2014)... Healthcare Services, Inc. ("DHS"), a portfolio company of GMH Ventures ... Equipment, Inc. ("Progressive") of Clarion, PA ... not disclosed. Progressive is a full service ... sleep, mobility, and respiratory products to customers in the western ...
(Date:1/14/2014)... N.Y. , Jan. 14, 2014   Oligomerix, Inc. , ... modifying therapeutics for Alzheimer,s disease (AD) and related neurodegenerative ... to Valhalla, NY as of ... laboratory space at New York Medical College. ...
Breaking Medicine Technology:Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2
... MEETING, Pa., Nov. 8, 2010 Keeping radiation ... hospitals, particularly in computed tomography (CT), which has undergone some ... side is that CT delivers some of the highest radiation ... measures for delivering the appropriate radiation dose can result in ...
... Biotechnologies Corporation, a leader in the emerging field of ... financial support for the company,s lead oncology product, Rexin-G, ... Services (HHS), and the National Institutes of Health (NIH) ... latest support for the clinical advancement of Rexin-G comes ...
Cached Medicine Technology:ECRI Institute Service to Address CT Radiation Dose Safety 2ECRI Institute Service to Address CT Radiation Dose Safety 3Epeius Biotechnologies Awarded Federal Grant Advancing Tumor-Targeted Cancer Therapy 2
Open blade design with aspiration capabilities for removing fluids from the operative site. 19 gauge wire....
Designed to provide open approaches of the keratome to the cornea for either the left or right eye. Lightweight wire design adds to the comfort of the instrument when in place....
Solid 14 mm free-swinging blades, suture posts, and stabilizing disk. Dull finish....
Designed for use with foster enucleation snare (E3670). Package of 12 stainless steel wires. Overall length 5.3 inches....
Medicine Products: